2nd Edition of International Cancer Research Conference
March 19-21, 2026 | Singapore
International Cancer Research Conference
Event Book
Event program
Scientific Program
About
The International Cancer Research Conference (Cancer Research 2025), held from March 24-26, 2025, in Singapore, was a resounding success. Centered around the theme "Breaking Barriers, Building Hope: Advancing Cancer Research and Care," the event highlighted cutting-edge research and breakthroughs that are transforming the landscape of cancer science. Leading experts, scientists, and industry pioneers from across the globe gathered to explore emerging trends and discuss innovations that could redefine the future of cancer treatment, prevention, and care. With dynamic keynote presentations, hands-on workshops, and abundant networking opportunities, the conference served as a vital platform for fostering collaboration and advancing the next wave of cancer research.
Scientific Committee Members
Rajvir Dahiya
University of California San Francisco, United States
Atif A Ahmed
University of Washington-Seattle Children’s Hospital, United States
Anyou Wang
DIFIBER LLC, United States
Patricia Tai
University of Saskatchewan, Canada
Michael Thompson
University of Toronto, Canada
Pietro Salvatori
Independent H&N Surgeon, ItalySpeakers
Patricia Tai
University of Saskatchewan, Canada
Michele Mishto
Francis Crick Institute, United Kingdom
Farid Moinfar
Ordensklinikum Linz Barmherzige Schwestern, Austria
Paulo Cesar De Morais
Catholic University of Brasilia, Brazil
Getachew Dagne
University of South Florida, United States
Eleni Petsalaki
University of Crete, Greece
Ratan Kumar Sarkar
Independent Researcher, India
K R Muralidhar
Karkinos Healthcare, IndiaGallery
Reviews
Title : Molecular-genetic study of low-grade and high-grade “basal-like” (triple-negative) breast carcinomas
Farid Moinfar, Ordensklinikum Linz Barmherzige Schwestern, Austria
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title : The role of artificial intelligence (AI) in oncology
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Altered expression of endoplasmic reticulum stress response genes and circular RNAs in oral squamous cell carcinoma tumorigenesis
Vandana Tiwari, Dr. Ram Manohar Lohia Institute of Medical Sciences, India
Title : The future of pharmacogenetic polymorphism, pharmacogenomics and pharmamicrobiome in cancer treatment
Bene Ekine-Afolabi, University of East London, United Kingdom